Baseline Characteristics and Study Quality of included Randomised Controlled Trials.

*BP not assessed in meta-analysis as both arms contained an anti-hypertensive;**Following placebo 12 weeks of cross-over RCT;#Double-blind 9-arm with varying medication components and number of components. Only three arms were used in this meta-analysis: the polycap, aspirin and simvastatin arms;BP = blood pressure and measured in mmHg; SBP = systolic blood pressure; DBP = Diastolic blood pressure; Total chol. = total cholesterol in mmol/L; LDL = LDL cholesterol in mmol/L; AE = adverse events; TLC = therapeutic lifestyle changes; SD = standard deviation; CVD = cardiovascular disease.* 本荟萃分析未评估血压（blood pressure, BP）相关指标，因两组干预臂均使用了降压药物； ** 随后开展了为期12周的安慰剂对照交叉随机对照试验； # 本试验采用双盲设计，共设置9个干预臂，各臂的药物组成及成分数量均存在差异。本荟萃分析仅纳入其中3个干预臂：复方制剂（polycap）臂、阿司匹林臂与辛伐他汀臂； BP即血压（blood pressure），测量单位为毫米汞柱（mmHg）；SBP即收缩压（systolic blood pressure）；DBP即舒张压（diastolic blood pressure）；Total chol.即总胆固醇（total cholesterol），单位为毫摩尔每升（mmol/L）；LDL即低密度脂蛋白胆固醇（low-density lipoprotein cholesterol），单位为毫摩尔每升（mmol/L）；AE即不良事件（adverse events）；TLC即治疗性生活方式干预（therapeutic lifestyle changes）；SD即标准差（standard deviation）；CVD即心血管疾病（cardiovascular disease）。